CLINICAL_TRIALS
withdrawal
· 2012-09-25
Clinical Trial Update: Management of Metastatic Breast Cancer in Frail Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating management of metastatic breast cancer in frail patients has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN